Brand Name Drug Maker Amylyx Sets Price Tag For Relyvrio Between Five And 17 Times Estimates For A Fair Price Despite Lack Of Data on Efficacy Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday reacting to brand name drug maker Amylyx setting a list price of $158,000 annually on the company’s new […]
Lawmakers Must Put Patients First And Reject Bogus Big Pharma Rhetoric Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to comments from some lawmakers suggesting a repeal of drug pricing solutions passed as part of the Inflation Reduction Act of 2022. “Washington finally took a major step forward to begin holding […]
Big Pharma Giant Eyes Massive Price Hike on COVID-19 Vaccine Developed with $1.3 Billion Investment from American Taxpayers Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday reacting to reports that brand name drug company Moderna is considering hiking the price of the company’s COVID-19 vaccine as funding for the shots shifts from the U.S. […]
Biden Administration and Congress Deliver Positive Progress on Longstanding Commitments to Lower Prescription Drug Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in response to President Biden signing H.R. 5376, the Inflation Reduction Act of 2022, into law. “CSRxP applauds President Biden for maintaining his commitment to lowering prescription drug […]
Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending Hundreds of Millions of Dollars on False and Hyperbolic Claims Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday on the U.S. House of Representatives’ passage of the Inflation Reduction Act of 2022. CSRxP has been a longtime advocate […]
Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down on the Pharmaceutical Industry’s Egregious Practices, Deliver Relief for American Patients Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Sunday on the U.S. Senate passage of the Inflation Reduction Act of 2022. CSRxP has been a longtime advocate […]
Bipartisan Interagency Patent Coordination and Improvement Act of 2022 Will Help Hold Brand Name Drug Companies Accountable, Support Pharmaceutical Competition Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday following the passage of the Interagency Patent Coordination and Improvement Act of 2022 in the U.S. Senate Committee on the Judiciary. The […]
Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma Accountable for Egregious Anti-Competitive and Pricing Practices to Lower Rx Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act. “CSRxP appreciates Senators Shaheen and Collins for their […]
Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While Pointing Fingers at Others to Evade Accountability Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to a first batch of price increases on brand name drugs from manufacturers as part of traditional biannual price hikes. Drug companies […]
Congress Should Swiftly Advance Solutions to Deliver Relief for Millions of Americans Hurt By Brand Name Drug Companies’ Egregious Practices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday reacting to reports Congressional leaders will introduce a revised reconciliation package with a significant focus on prescription drug prices. “CSRxP applauds the […]